• Investieren in die Biotechnologie – ein aktiver Ansatz zahlt sich aus

    1 September 2019
    Download

  • U.S. FDA accepts for review Viela Bio's first BLA filing

    27 August 2019
    Download

  • Harmony Biosciences Announces FDA Approval of WAKIX (pitolisant), a First-In-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy

    15 August 2019
    Download

  • Interview with Andreas Wicki

    14 August 2019
    Download

  • Interview with Ivo Staijen

    17 July 2019
    Download

  • SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline to Evaluate Nirogacestat in Combination with Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma

    27 June 2019
    Download

  • 1mg to accelerate investments in Growth, Supply Chain & AI/ML driven personalized care

    27 June 2019
    Download

  • Viela Bio Closes $75 Million Series B Financing

    17 June 2019
    Download

  • Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab

    13 June 2019
    Download

  • SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for the Treatment of a Severe Form of Neurofibromatosis Type 1

    3 June 2019
    Download

  • Biotech-Unternehmen schwimmen im Geld

    25 May 2019
    Download

  • «Ungebremste Innovationskraft»

    1 May 2019
    Download

  • Unbridled Capacity for Innovation

    1 May 2019
    Download

  • Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor

    24 April 2019
    Download

  • Arrakis Therapeutics Raises $75M Series B To Develop Small-Molecule Medicines Targeting RNA

    18 April 2019
    Download

  • HOOKIPA Pharma Announces Pricing of Initial Public Offering

    17 April 2019
    Download

  • SpringWorks Therapeutics Completes $125 Million Series B Financing

    1 April 2019
    Download

  • iTeos Therapeutics Announces Eight Data Presentations for A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Annual Meeting 2019

    29 March 2019
    Download

  • HOOKIPA PROPOSES IPO AS ITS CANCER VACCINES HEAD TOWARDS THE CLINIC

    22 March 2019
    Download

  • Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

    21 March 2019
    Download

  • Forbius Announces the First Patient Dosed in a Phase 1b Diffuse Cutaneous Systemic Sclerosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor

    4 March 2019
    Download

  • Principia Biopharma Announces Positive Data from Phase 2 Pemphigus Vulgaris Trial at 2019 American Academy of Dermatology Annual Meeting in Late-Breaking Presentation

    2 March 2019
    Download

  • HOOKIPA Pharma Raises $37.4 million (?33.2 million) in Series D Financing

    26 February 2019
    Download

  • Forbius Announces a Clinical Trial Collaboration with the Myeloproliferative Neoplasm Research Consortium to Evaluate AVID200 a Novel TGF beta Inhibitor in Myelofibrosis

    14 February 2019
    Download

  • Harmony Biosciences announces file acceptance of its new drug application for pitolisant

    12 February 2019
    Download
    • More news